|
JUNB
|
JunB proto-oncogene, AP-1 transcription factor subunit |
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- Interleukin-4 and Interleukin-13 signaling
- NGF-stimulated transcription
- NGF-stimulated transcription
- Nuclear events stimulated by ALK signaling in cancer
|
|
|
|
JUND
|
JunD proto-oncogene, AP-1 transcription factor subunit |
- Estrogen-dependent gene expression
- NGF-stimulated transcription
- NGF-stimulated transcription
- Regulation of PD-L1(CD274) transcription
|
|
|
|
JUP
|
junction plakoglobin |
- Adherens junctions interactions
- VEGFR2 mediated vascular permeability
- Neutrophil degranulation
- Keratinization
- Formation of the cornified envelope
- RHOA GTPase cycle
- RHOB GTPase cycle
- RHOC GTPase cycle
- CDC42 GTPase cycle
- RHOQ GTPase cycle
- RHOH GTPase cycle
- RHOJ GTPase cycle
- Regulation of CDH11 function
- Regulation of CDH11 function
- Regulation of CDH19 Expression and Function
- Regulation of CDH1 Function
- Degradation of CDH1
- Regulation of CDH1 posttranslational processing and trafficking to plasma membrane
- CDH11 homotypic and heterotypic interactions
|
|
- Naxos disease and Carvajal syndrome
- Arrhythmogenic right ventricular cardiomyopathy (ARVC)
|
|
KAT5
|
lysine acetyltransferase 5 |
- Formation of the beta-catenin:TCF transactivating complex
- Formation of the beta-catenin:TCF transactivating complex
- DNA Damage/Telomere Stress Induced Senescence
- HATs acetylate histones
- HDR through Single Strand Annealing (SSA)
- HDR through Homologous Recombination (HRR)
- Sensing of DNA Double Strand Breaks
- Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
- Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
- Resolution of D-loop Structures through Holliday Junction Intermediates
- Nonhomologous End-Joining (NHEJ)
- Homologous DNA Pairing and Strand Exchange
- Processing of DNA double-strand break ends
- Presynaptic phase of homologous DNA pairing and strand exchange
- Regulation of TP53 Activity through Phosphorylation
- G2/M DNA damage checkpoint
- Estrogen-dependent gene expression
- Defective homologous recombination repair (HRR) due to BRCA1 loss of function
- Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
- Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function
- Impaired BRCA2 binding to RAD51
- Impaired BRCA2 binding to PALB2
- Cardiogenesis
|
- Coenzyme A
- S-Acetyl-Cysteine
|
|
|
KDM1A
|
lysine demethylase 1A |
- HDACs deacetylate histones
- HDMs demethylate histones
- Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
- Regulation of PTEN gene transcription
- Estrogen-dependent gene expression
- NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
- Potential therapeutics for SARS
- Negative Regulation of CDH1 Gene Transcription
- Factors involved in megakaryocyte development and platelet production
|
|
|
|
KIF1B
|
kinesin family member 1B |
- COPI-dependent Golgi-to-ER retrograde traffic
- Kinesins
|
|
- Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
|
|
KPNA2
|
karyopherin subunit alpha 2 |
- CaMK IV-mediated phosphorylation of CREB
- ISG15 antiviral mechanism
- NS1 Mediated Effects on Host Pathways
- CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
- Sensing of DNA Double Strand Breaks
- Estrogen-dependent gene expression
- SARS-CoV-1 activates/modulates innate immune responses
- SARS-CoV-2 activates/modulates innate and adaptive immune responses
|
|
|
|
KPNA6
|
karyopherin subunit alpha 6 |
- Assembly of the ORC complex at the origin of replication
|
|
|
|
LARP7
|
La ribonucleoprotein 7, transcriptional regulator |
|
|
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase |
- GPVI-mediated activation cascade
- PIP3 activates AKT signaling
- Signaling by SCF-KIT
- Signaling by SCF-KIT
- Regulation of KIT signaling
- Nef and signal transduction
- Nef Mediated CD4 Down-regulation
- Downstream TCR signaling
- Phosphorylation of CD3 and TCR zeta chains
- Translocation of ZAP-70 to Immunological synapse
- Generation of second messenger molecules
- PECAM1 interactions
- Constitutive Signaling by Aberrant PI3K in Cancer
- DAP12 signaling
- DAP12 signaling
- Co-stimulation by CD28
- CD28 dependent PI3K/Akt signaling
- CD28 dependent Vav1 pathway
- Co-inhibition by CTLA4
- Co-inhibition by PD-1
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- RHOH GTPase cycle
- Interleukin-2 signaling
- Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
- FLT3 signaling through SRC family kinases
|
- Dasatinib
- AP-22408
- Staurosporine
- 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
- {4-[(2S)-2-Acetamido-3-({(1S)-1-[3-carbamoyl-4-(cyclohexylmethoxy)phenyl]ethyl}amino)-3-oxopropyl]-2-phosphonophenoxy}acetic acid
- Phosphoaminophosphonic Acid-Adenylate Ester
- 3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE
- 2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE
- 5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE
- N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine
- N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine
- N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine
- Ponatinib
- Nintedanib
- Fostamatinib
- Zanubrutinib
- Zotiraciclib
|
- Combined immunodeficiencies (CIDs), including the following nine diseases: X-linked hyper IgM syndrome; CD40 deficiency hyper IgM syndrome; Purine nucleoside phosphorylase (PNP) deficiency; Omenn syndrome; MHC deficiency (HLA-class I); MHC deficiency (HLA-class II); Zap-70 deficiency; p56 Lck deficiency; CD8 deficiency
|
|
LCMT1
|
leucine carboxyl methyltransferase 1 |
- Cyclin A/B1/B2 associated events during G2/M transition
|
|
|
|
LDHC
|
lactate dehydrogenase C |
|
|
|
|
LMNTD1
|
lamin tail domain containing 1 |
|
|
|
|
LMO4
|
LIM domain only 4 |
|
|
|
|
LONRF1
|
LON peptidase N-terminal domain and ring finger 1 |
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
|
MACROH2A1
|
macroH2A.1 histone |
|
|
|
|
MAN2C1
|
mannosidase alpha class 2C member 1 |
- Lysosomal oligosaccharide catabolism
|
|
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1 |
- MyD88:MAL(TIRAP) cascade initiated on plasma membrane
- FCERI mediated MAPK activation
- FCERI mediated MAPK activation
- TRAF6 mediated NF-kB activation
- TRAF6 mediated NF-kB activation
- TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
- MyD88 cascade initiated on plasma membrane
|
- AZD-8330
- Binimetinib
- Fostamatinib
|
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14 |
- CD28 dependent PI3K/Akt signaling
- Dectin-1 mediated noncanonical NF-kB signaling
- TNFR2 non-canonical NF-kB pathway
- NIK-->noncanonical NF-kB signaling
- TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
|
|
|
|
MAP3K3
|
mitogen-activated protein kinase kinase kinase 3 |
|
|
|